162 related articles for article (PubMed ID: 35169210)
1. Synergistic effect of plasma-activated medium and novel indirubin derivatives on human skin cancer cells by activation of the AhR pathway.
Rebl H; Sawade M; Hein M; Bergemann C; Wende M; Lalk M; Langer P; Emmert S; Nebe B
Sci Rep; 2022 Feb; 12(1):2528. PubMed ID: 35169210
[TBL] [Abstract][Full Text] [Related]
2. A Thia-Analogous Indirubin
Wendt F; Wittig F; Rupprecht A; Ramer R; Langer P; Emmert S; Frank M; Hinz B
Cells; 2023 Oct; 12(19):. PubMed ID: 37830623
[TBL] [Abstract][Full Text] [Related]
3. An indirubin derivative, indirubin-3'-monoxime suppresses oral cancer tumorigenesis through the downregulation of survivin.
Lo WY; Chang NW
PLoS One; 2013; 8(8):e70198. PubMed ID: 23967071
[TBL] [Abstract][Full Text] [Related]
4. A Sensitive LC-MS/MS Method for the Simultaneous Determination of Two Thia-Analogous Indirubin
Fischle A; Schwarz R; Wendt F; Kordt M; Ramer R; Boeckmann L; Hein M; Langer P; Emmert S; Vollmar B; Hinz B
Molecules; 2022 May; 27(9):. PubMed ID: 35566381
[TBL] [Abstract][Full Text] [Related]
5. Rational combinations of indirubin and arylidene derivatives exhibit synergism in human non-small cell lung carcinoma cells.
Rajagopalan P; Dera A; Abdalsamad MR; C Chandramoorthy H
J Food Biochem; 2019 Jul; 43(7):e12861. PubMed ID: 31353710
[TBL] [Abstract][Full Text] [Related]
6. Indirubin-3'-monoxime promotes autophagic and apoptotic death in JM1 human acute lymphoblastic leukemia cells and K562 human chronic myelogenous leukemia cells.
Lee MY; Liu YW; Chen MH; Wu JY; Ho HY; Wang QF; Chuang JJ
Oncol Rep; 2013 May; 29(5):2072-8. PubMed ID: 23468088
[TBL] [Abstract][Full Text] [Related]
7. Critical role of Bid and Bax in indirubin-3'-monoxime-induced apoptosis in human cancer cells.
Shi J; Shen HM
Biochem Pharmacol; 2008 May; 75(9):1729-42. PubMed ID: 18377873
[TBL] [Abstract][Full Text] [Related]
8. Indirubin-3-monoxime and thymoquinone exhibit synergistic efficacy as therapeutic combination in in-vitro and in-vivo models of Lung cancer.
Dera AA; Rajagopalan P; Al Fayi M; Ahmed I; Chandramoorthy HC
Arch Pharm Res; 2020 Jun; 43(6):655-665. PubMed ID: 32588331
[TBL] [Abstract][Full Text] [Related]
9. Indirubin-3'-monoxime, a CDK inhibitor induces growth inhibition and apoptosis-independent up-regulation of survivin in transitional cell cancer.
Perabo FG; Frössler C; Landwehrs G; Schmidt DH; von Rücker A; Wirger A; Müller SC
Anticancer Res; 2006; 26(3A):2129-35. PubMed ID: 16827155
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative and apoptosis inducing effects of indirubin-3'-monoxime in renal cell cancer cells.
Perabo FG; Landwehrs G; Frössler C; Schmidt DH; Mueller SC
Urol Oncol; 2011; 29(6):815-20. PubMed ID: 19945313
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of indirubin-3'-monoxime against human osteosarcoma.
Zhang Y; Song L; Li J; Zhang Y; Lu X; Zhang B
IUBMB Life; 2019 Oct; 71(10):1465-1474. PubMed ID: 31050877
[TBL] [Abstract][Full Text] [Related]
12. Indole-3-carbinol induces tumor cell death: function follows form.
Megna BW; Carney PR; Nukaya M; Geiger P; Kennedy GD
J Surg Res; 2016 Jul; 204(1):47-54. PubMed ID: 27451867
[TBL] [Abstract][Full Text] [Related]
13. The aryl hydrocarbon receptor ligand ITE inhibits cell proliferation and migration and enhances sensitivity to drug-resistance in hepatocellular carcinoma.
Zhang X; He B; Chen E; Lu J; Wang J; Cao H; Li L
J Cell Physiol; 2021 Jan; 236(1):178-192. PubMed ID: 32510618
[TBL] [Abstract][Full Text] [Related]
14. Activation of the aryl hydrocarbon receptor by 3-methylcholanthrene, but not by indirubin, suppresses mammosphere formation via downregulation of CDC20 expression in breast cancer cells.
Yamashita N; Yoshizuka A; Kase A; Ozawa M; Taga C; Sanada N; Kanno Y; Nemoto K; Kizu R
Biochem Biophys Res Commun; 2021 Sep; 570():131-136. PubMed ID: 34280616
[TBL] [Abstract][Full Text] [Related]
15. 5-Nitro-5'-hydroxy-indirubin-3'-oxime (AGM130), an indirubin-3'-oxime derivative, inhibits tumor growth by inducing apoptosis against non-small cell lung cancer in vitro and in vivo.
Ahn MY; Kim TH; Kwon SM; Yoon HE; Kim HS; Kim JI; Kim YC; Kang KW; Ahn SG; Yoon JH
Eur J Pharm Sci; 2015 Nov; 79():122-31. PubMed ID: 26342773
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of indirubin and 2,3,7,8-tetrachlorodibenzo-p-dioxin on the aryl hydrocarbon receptor (AhR) signalling in liver progenitor cells.
Procházková J; Kozubík A; Machala M; Vondráček J
Toxicology; 2011 Jan; 279(1-3):146-54. PubMed ID: 20951181
[TBL] [Abstract][Full Text] [Related]
17. Aryl hydrocarbon receptor response to indigoids in vitro and in vivo.
Peter Guengerich F; Martin MV; McCormick WA; Nguyen LP; Glover E; Bradfield CA
Arch Biochem Biophys; 2004 Mar; 423(2):309-16. PubMed ID: 15001395
[TBL] [Abstract][Full Text] [Related]
18. Indirubin-3'-monoxime inhibits autophosphorylation of FGFR1 and stimulates ERK1/2 activity via p38 MAPK.
Zhen Y; Sørensen V; Jin Y; Suo Z; Wiedłocha A
Oncogene; 2007 Sep; 26(44):6372-85. PubMed ID: 17533378
[TBL] [Abstract][Full Text] [Related]
19. Indirubin-pregnane X receptor-JNK axis accelerates skin wound healing.
Tanaka Y; Uchi H; Ito T; Furue M
Sci Rep; 2019 Dec; 9(1):18174. PubMed ID: 31796845
[TBL] [Abstract][Full Text] [Related]
20. Induction of discrete apoptotic pathways by bromo-substituted indirubin derivatives in invasive breast cancer cells.
Nicolaou KA; Liapis V; Evdokiou A; Constantinou C; Magiatis P; Skaltsounis AL; Koumas L; Costeas PA; Constantinou AI
Biochem Biophys Res Commun; 2012 Aug; 425(1):76-82. PubMed ID: 22820195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
